Other Clinical Trial - Impact of Different Hemostasis Methods on Ovarian

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05514028` - Evaluation of Salivary RNAs in the Presence of an Adnexal Mass of Ovarian Origin
Not yet recruiting	`NCT04788498` - Laparoscopic Single-site Surgery Versus Conventional Entry in Ovarian Cystectomy	N/A
Recruiting	`NCT04224467` - The Application of Real-Time Near-infrared Imaging in Gynecological Surgery	N/A
Completed	`NCT03374397` - PReservation Study of Ovarian Function And Hemostasis, and Its Safety of Surgiguard@ During Laparoscopic Ovarian Cystectomy	Phase 3

See also

Status

Clinical Trial

Phase

Recruiting

NCT05514028 - Evaluation of Salivary RNAs in the Presence of an Adnexal Mass of Ovarian Origin

Not yet recruiting

NCT04788498 - Laparoscopic Single-site Surgery Versus Conventional Entry in Ovarian Cystectomy

N/A

Recruiting

NCT04224467 - The Application of Real-Time Near-infrared Imaging in Gynecological Surgery

N/A

Completed

NCT03374397 - PReservation Study of Ovarian Function And Hemostasis, and Its Safety of Surgiguard@ During Laparoscopic Ovarian Cystectomy

Phase 3

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT06350227
Study type	Interventional
Source	West China Second University Hospital
Contact	Yanru Long
Phone	86-13550169017
Email	2801443341@qq.com
Status	Recruiting
Phase	N/A
Start date	January 4, 2024
Completion date	June 2026

Impact of Different Hemostasis Methods on Ovarian Function and Fertility During Laparoscopic Ovarian Cystectomy of Benign Ovarian Cyst

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms